Johnson & Johnson (NYSE: JNJ) announced today that 11 oral presentations from the Company’s industry-leading solid tumor portfolio and pipeline will be featured at the 2024 World Conference on Lung Cancer (WCLC) and the European Society for Medical Oncology (ESMO) 2024 Congress. Twenty-seven studies (23 company-sponsored and four investigator-initiated), including four late-breaking abstracts, will feature new data in lung, bladder, prostate, and colorectal cancers. Continue reading
Category Archives: Reasearch
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval of its in vitro diagnostic (IVD) TruSight™ Oncology (TSO) Comprehensive test and its first two companion diagnostic (CDx) indications. This single test interrogates over 500 genes to profile a patient’s solid tumor, helping to increase the likelihood of identifying an immuno-oncology biomarker or clinically actionable biomarkers that enable targeted therapy options or clinical trial enrollment. Continue reading
Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19
TrialSite News features a paper published today in Viruses (Basel), authored by an international team of researchers, including two fellows of their nations’ academies of sciences (Colleen Aldous, senior author Wendy Hoy) and others who participated in Nobel prize-honored research (Thomas Borody, Morimasa Yagisawa). The publication reveals how coronavirus biochemistry well-established over past decades governs the morbidities of COVID-19, risk factors and therapeutic approaches. Continue reading
Playing a musical instrument or singing in a choir may boost your brain – new study
Michael Hornberger, University of East Anglia
Generations of parents have told their children to practice their musical instruments. Parents have good reason to keep on top of their children’s musical education, since learning an instrument is not only associated with better educational attainment but also cognition (thinking) and even intelligence scores in children. But does this musicality translate to better cognition later in life?
Large-scale proteomics in population-based studies from UK and Iceland
n an article revealed today in Nature, scientists from deCODE Genetics, a subsidiary of the pharmaceutical company Amgen, demonstrated how plasma proteomics can contribute to a better understanding of diseases. The study’s focus on the plasma proteome led the team to find associations between various diseases and the levels of specific proteins. “Measuring a great number of proteins in a population-based cohort enables the discovery of circulating biomarkers and the early detection of disease,” says Patrick Sulem, scientist at deCODE genetics and one of the senior authors on the paper. Continue reading
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its annual Companies to Watch report. This year’s report identifies seven innovators trying to change the drug discovery and development paradigm by utilizing innovative artificial intelligence (AI) and machine learning (ML) technologies. Drawing on data and analytics from BioWorld, published by Clarivate, paired with analysis of drug benefits, financing, R&D activity and more, this report explores why Clarivate believes these innovators stand out and what makes them companies to watch. Continue reading
Top 10 Rare Blood Cancer Symptoms Revealed at Novartis’ Immersive Installation
Novartis UK is pleased to announce the launch of the immersive MPN 10 exhibition at Westfield London (White City) which shines a light on the symptoms of a group of rare blood cancers called myeloproliferative neoplasms (MPNs). The 10 bespoke sculptures have been exclusively designed by five mural artists from around the UK, with London Artist, Frankie Strand, designing numbers 7 and 9. Continue reading
Economist Impact research shows climate change associations-including increasing heatwaves and pollen-are affecting lung health
Today Economist Impact, an arm of The Economist Group that works with organisations globally to further their missions, released research supported by Chiesi Group, a pharmaceutical company, exploring the links between air quality, health inequalities and lung health. A survey of 500 people found that, despite reductions in the concentration of key air pollutants, poor air quality negatively affects symptoms, overall health and quality of life for people living with lung conditions. Continue reading
Heart Failure start-up, Acorai, embarks on the next vital stage towards regulatory approval
Today, Acorai, a start-up medical device manufacturer from Sweden, has announced the initiation of a global clinical trial with the enrollment of its first patient in London, UK. Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024. Continue reading
Mount Sinai Researchers Uncover How Mammary Glands Control Overall Energy Balance and Fat Metabolism
An Icahn School of Medicine at Mount Sinai study sheds light on the intricate interplay between mammary adipose (fat) tissue and breast health, and offers exciting possibilities for understanding breast development, lactation, cancer, and obesity and related metabolic disorders. Continue reading